- Martina Caiazza, MDDepartment of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Naples, ItalyInterests: rare cardiovascular disease; genetic disease; genetic tests; genomics
- Emanuele Monda, MDDepartment of Translational Medical Sciences, Inherited and Rare Heart Disease, Vanvitelli Cardiology, University of Campania Luigi Vanvitelli, Naples, ItalyInterests: rare cardiovascular disease; genetic disease; cardiomyopathies; sudden cardiac death; genetic tests
- Cristina Chimenti, MDDepartment of Clinical, Internal, Anesthesiologist and Cardiovascular Sciences, La Sapienza University, Rome, Italy
The perception of genetic cardiovascular diseases has significantly changed over the last two decades.
The growth of cardiovascular genetics is attributed to the recent advances in genome sequencing, genetic testing, and the expanding understanding of the genetic basis of different cardiac conditions, including channelopathies, cardiomyopathies, lipid disorders, vascular diseases, and several other genetic conditions affecting the cardiovascular system. It has also contributed to a significant improvement in specific therapies, with the possibility to ameliorate symptoms, slow disease progression, and mitigate outcomes of patients with genetic diseases.
In patients with the possibility of a genetic cardiovascular disease, integration of the information obtained from clinical examination, imaging studies, and genetic testing can improve diagnosis, prognostication, and cascade family screening to identify asymptomatic affected patients, and, if possible, provide them with genotype-specific therapy.
This research topic aims to assemble novel research in the field of genetic cardiovascular diseases.
Articles may include investigations of: clinical genetics as applied to the diagnosis and management of monogenic or oligogenic cardiovascular disorders; molecular basis of complex cardiovascular disorders; pharmacogenomics; regulation of gene expression; gene therapy and therapeutic genomic editing; systems biology approaches to the diagnosis and management of cardiovascular disorders; and novel applications of precision medicine.
The Topic Editors welcome original research articles, reviews, perspectives, hypotheses and theories, general commentaries, and opinions to be submitted for this research topic.
Prof. Giuseppe Limongelli, Dr. Martina Caiazza, Dr. Emanuele Monda and Dr. Cristina Chimenti
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.